Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-2-23
pubmed:abstractText
The use of circulating progenitor cell support following high-dose chemotherapy for malignancies decreases but does not entirely abolish platelet transfusion requirement. We investigated the feasibility of supporting the posttransplant thrombocytopenic phase exclusively with autologous platelets collected by apheresis and cryopreserved.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0042-9007
pubmed:author
pubmed:issnType
Print
pubmed:volume
75
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
224-9
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:9852411-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:9852411-Blood Platelets, pubmed-meshheading:9852411-Blood Preservation, pubmed-meshheading:9852411-Blood Transfusion, Autologous, pubmed-meshheading:9852411-Breast Neoplasms, pubmed-meshheading:9852411-Combined Modality Therapy, pubmed-meshheading:9852411-Cyclophosphamide, pubmed-meshheading:9852411-Epirubicin, pubmed-meshheading:9852411-Female, pubmed-meshheading:9852411-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:9852411-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:9852411-Humans, pubmed-meshheading:9852411-Melphalan, pubmed-meshheading:9852411-Methotrexate, pubmed-meshheading:9852411-Platelet Transfusion, pubmed-meshheading:9852411-Thiotepa, pubmed-meshheading:9852411-Thrombocytopenia
pubmed:year
1998
pubmed:articleTitle
Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
pubmed:affiliation
Servizio di Immunoematologia e Trasfusione, IRCCS Policlinico San Matteo, Italia.
pubmed:publicationType
Journal Article